Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Supportive Care in Cancer
Erschienen in: Supportive Care in Cancer 5/2021

20.11.2020 | Commentary

Palliative care in onco-hematology: a perspective

verfasst von: Maria Eduarda Couto, José Ferraz-Gonçalves

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Palliative care (PC) is focused on individualized symptomatic control, psychological help, and support in the context of severe disease. Oncologic patients are still the most referred to PC and hematologic patients are only 7%. This is a commentary about PC applied to hematologic patients. There is evidence supporting that these patients behave as a special group in PC when compared with other tumors: there is a smaller number of referrals, with more advanced disease status, more symptomatology expressed, and less time between the last treatment date and the referral date or death. This article also expresses the experience of an oncologic palliative care unit. More health education programs in PC are needed for specialized professionals in hematology, as well as a change of nowadays health politics, in order to increase the participation of this specialized care in hematology.
Literatur
1.
Hughes MT, Smith TJ (2014) The growth of palliative care in the United States. Annu Rev Public Health 35:459–475CrossRef
2.
LeBlanc TW, El-Jawahri A (2015) When and why should patients with hematologic malignancies see a palliative care specialist? Hematology Am Soc Hematol Educ Program 2015:471–478CrossRef
3.
Alt-Epping B, Wulf G, Nauck F (2011) Palliative care for patients with hematological malignancies-a case series. Ann Hematol 90(5):613–615CrossRef
4.
Clark D (2010) International progress in creating palliative medicine as a specialized discipline, Fourth edn. Oxford University Press, pp 9–16
5.
6.
LeBlanc TW, Roeland EJ, El-Jawahri A (2017) Early palliative care for patients with hematologic malignancies: is it really so difficult to achieve? Curr Hematol Malig Rep 12(4):300–308CrossRef
7.
Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T, Stovall EL, Zimmermann C, Smith TJ (2017) Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline update. J Clin Oncol 35(1):96–112CrossRef
8.
Couto ME, Oliveira I, Mariz M, Ferraz-Gonçalves J (2019) The profile of the onco-hematology patient in the palliative care: 4 years of experience. Porto Biomed J 4(6):e39CrossRef
9.
LeBlanc TW, Abernethy AP, Casarett DJ (2015) What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network. J Pain Symptom Manag 49(3):505–512CrossRef
10.
Howell DA, Shellens R, Roman E, Garry AC, Patmore R, Howard MR (2011) Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data. Palliat Med 25(6):630–641CrossRef
11.
Freeman AT, Wood WA, Fox A, Hanson LC (2018) Access to palliative care consultation and advance care planning for adults with high-risk leukemia. J Palliat Med 21(2):225–228CrossRef
12.
Hui D, Didwaniya N, Vidal M, Shin SH, Chisholm G, Roquemore J, Bruera E (2014) Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer. 120(10):1572–1578CrossRef
13.
LeBlanc T, Abernathy A, Casarett D (2013) Palliative care for patients with hematologic malignancies: a profile of patients with blood cancers referred to the CHOICE hospice network. Blood. 122(21):1678–1678CrossRef
14.
Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ (2008) Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 26(23):3860–3866CrossRef
15.
Beaussant Y, Etienne D, Chauchet A et al (2018) Hospital end-of-life care in haematological malignancies. BMJ Support Palliat Care 8:314–324CrossRef
16.
Hennessy JE, Lown BA, Landzaat L, Porter-Williamson K (2013) Practical issues in palliative and quality-of-life care. J Oncol Pract 9(2):78–80CrossRef
17.
McCaughan D, Roman E, Smith AG, Garry A, Johnson M, Patmore R, Howard M, Howell DA (2018) Determinants of hospital death in haematological cancers: findings from a qualitative study. BMJ Support Palliat Care 8(1):78–86CrossRef
18.
McCaugh D, Roman E, Smith AG et al (2019) Perspectives of bereaved relatives of patients with hematological malignancies concerning preferred place of care and death: a qualitative study. J Palliat Med 33(5):518–530CrossRef
19.
McCaugh D, Roman E, Smith AG et al (2018) Palliative care specialists’ perceptions concerning referral of hematology patients to their services: findings from a qualitative study. BMC Palliat Care 17:33CrossRef
20.
Hui D, Park M, Liu D, Reddy A, Dalal S, Bruera E (2015) Attitudes and beliefs toward supportive and palliative care referral among hematologic and solid tumor oncology specialists. Oncologist. 20(11):1326–1332CrossRef
21.
LeBlanc TW, O’Donnell JD, Crowley-Matoka M et al (2015) Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. J Oncol Pract 11(2):E230–E2E8CrossRef
22.
Niscola P, Tendas A, Scaramucci L, Giovannini M (2014) End of life care in hematology: still a challenging concern. Ann Palliat Med 3(1):7–11PubMed
23.
Manitta VJ, Philip JA, Cole-Sinclair MF (2010) Palliative care and the hemato-oncological patient: can we live together? A review of the literature. J Palliat Med 13(8):1021–1025CrossRef
24.
Brurera E, Hui D (2012) Conceptual models for integrating palliative care at cancer center. J Palliat Med 15(11):1261–1268CrossRef
25.
26.
Chung H, Lycklom L, Smith TJ (2009) Palliative care in BMT. Bone Marrow Transplant 43(4):265–273CrossRef
27.
Niscola P, Tendas A, Efficace F (2018) Early care in patients with hematological malignancies: whre do we go from here. J Pain Symptom Manag 55(4):e1–e2CrossRef
28.
Quiñoa-Salanova, Porta-Sales J, Monforte-Royo C, Edo-Gual M (2019) The experiences and needs of primary family caregivers of patients with multiple myeloma: a qualitative analysis. J Palliat Med 33(5):500–509CrossRef
29.
LeBlanc TW (2014) Palliative care and hematologic malignancies: old dog, new tricks? J Oncol Pract 10(6):e404–e407CrossRef
30.
Button E, Bolton M, Chan RJ, Chambers S, Butler J, Yates P (2019) A palliative care model and conceptual approach suited to clinical malignant hematology. Palliat Med 33(5):483–485.sCrossRef
Metadaten
Titel
Palliative care in onco-hematology: a perspective
verfasst von
Maria Eduarda Couto
José Ferraz-Gonçalves
Publikationsdatum
20.11.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05895-y

Weitere Artikel der Ausgabe 5/2021

Supportive Care in Cancer 5/2021 Zur Ausgabe

Original Article

Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)

Original Article

Factors influencing spiritual well-being in terminally ill cancer inpatients in Japan

Original Article

Exploring the perceptions of cancer survivors of a mindfulness intervention at a tertiary hospital in Singapore: a descriptive qualitative study

Original Article

Detection of early changes in the muscle properties of the pectoralis major in breast cancer patients treated with radiotherapy using a handheld myotonometer

Original Article

The silent transition from curative to palliative treatment: a qualitative study about cancer patients’ perceptions of end-of-life discussions with oncologists

Original Article

Informal caregiver well-being during and after patients’ treatment with adjuvant chemotherapy for colon cancer: a prospective, exploratory study

Neu im Fachgebiet Onkologie

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

23.05.2024 Leitsymptome in der Hausarztpraxis Nachrichten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise